[Prediction of improvement of left ventricular systolic function by dobutamine echocardiography after recent
O Lozé1, S Tassan-Mangina, P Nazeyrollas
1Département de cardiologie et pathologie vasculaire, hôpital Robert-Debré, CHU de Reims, avenue du Général-Koenig, 51092 Reims.
Insights
Low dose dobutamine echocardiography can predict myocardial recovery after heart attack. Viable heart segments identified by this method showed improved function, aiding revascularization decisions in patients without primary angioplasty.
Area of Science:
- Cardiology
- Diagnostic Imaging
- Myocardial Infarction
Background:
- Left ventricular ejection fraction is a key prognostic indicator in ischemic heart disease.
- Myocardial stunning post-infarction can cause reversible wall motion abnormalities.
- Predicting functional recovery is crucial for guiding treatment decisions.
Purpose of the Study:
- To evaluate low dose dobutamine echocardiography for predicting left ventricular systolic function improvement.
- To assess the potential of dobutamine stress testing in identifying viable myocardium after recent myocardial infarction.
- To determine the role of this technique in guiding revascularization strategies for patients not undergoing primary angioplasty.
Main Methods:
- A study involving 21 patients with recent myocardial infarction without primary angioplasty.
- Administration of low dose dobutamine (up to 20 micrograms/Kg/min) to assess myocardial viability and function.
- Echocardiography performed to evaluate segmental wall motion and left ventricular ejection fraction.
- Control echocardiography at 8 weeks post-treatment to assess functional recovery.
Main Results:
- Detection of myocardial viability using low dose dobutamine was associated with improved wall motion in 74% of affected segments.
- Segments identified as non-viable showed no significant improvement in 76% of cases, regardless of revascularization.
- Low dose dobutamine echocardiography demonstrated sensitivity of 71%, specificity of 79%, positive predictive value of 74%, and negative predictive value of 76% for predicting myocardial recovery.
Conclusions:
- Low dose dobutamine echocardiography is a valuable tool for predicting myocardial recovery after infarction.
- The technique can aid in decision-making regarding revascularization in patients not treated with primary angioplasty.
- Identifying viable myocardium is crucial for improving left ventricular function and patient outcomes.
Abstract:
Left ventricular ejection fraction is a major prognostic factor of ischaemic heart disease. In the early phase of myocardial infarction, part of the myocardium may be stunned and responsible for marked segmental wall dysfunction which is potentially reversible. The authors studied the potential of low dose dobutamine echocardiography to predict secondary improvement of left ventricular systolic function in 21 patients with recent inaugural myocardial infarction without primary angioplasty. All patients were treated and the investigation was carried out up to 20 micrograms/Kg/min of dobutamine without unwanted side-effects or myocardial ischaemia. The detection of viability by this method was associated with improved wall motion of the affected segments in 74% of cases, most of which had benefited from myocardial revascularisation at control echocardiography performed 8 weeks later. If 4 or more segments were estimated to be viable initially, the left ventricular ejection fraction improved to a value comparable to that obtained at a dosage of 20 micrograms/Kg/min of dobutamine. On the other hand, there was no secondary improvement in 76% of segments estimated to be non-viable whether or not they had been revascularised. The sensitivity, specificity, positive and negative predictive values of low dose dobutamine echocardiography for prediction of myocardial recovery after recent infarction were respectively 71, 79, 74 and 76%. The results of this investigation show prognostic value and could be an aid to the decision concerning revascularisation of patients not having undergone primary angioplasty.